You are here: Industry Insights > cell

News List

Lonza Launches Cryopreserved Leukopaks contractpharma
January 29, 2021
Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.
The drug aprotinin inhibits entry of SARS-CoV2 in host cells worldpharmanews
November 26, 2020
The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell.
Novel gelatin microcarrier developed to enhance cell production europeanpharmaceuticalreview
November 06, 2020
Researchers who developed the dissolvable microcarrier for large-scale cell production and expansion say it offers higher yield and cost-effectiveness compared to traditional methods.
Reaction Biology and 4HF Biotec Collaborate contractpharma
October 22, 2020
Reaction Biology, a drug discovery CRO with offices in Pennsylvania and Germany, and 4HF Biotec GmbH, a bioinformatics firm based in Freiburg, Germany, have announced a new cell-based service offering that combines Reaction Biology's ProLiFiler cell ...
FibroGenesis Inks Manufacturing Agreement contractpharma
September 30, 2020
Engages CDMO iBiologics to manufacture proprietary fibroblasts.
Gemini Bio Launches Moxi V contractpharma
July 22, 2020
Gemini Bioproducts LLC, a supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, has launched the Moxi V for precision cell analysis.
Sustainable biomedical device promising for regenerative medicine, say researchers europeanpharmaceuticalreview
July 07, 2020
The sustainable device, consisting of food industry by-products, had excellent biocompatibility both in vitro and in vivo.
Flow cytometry market expected to reach $6.36 billion by 2027 europeanpharmaceuticalreview
March 13, 2020
New research suggests the flow cytometry sector will grow at a CAGR of 8.2 percent due to increased adoption and expanding uses.
Almost 400 cell and gene therapies in US pipeline, finds report europeanpharmaceuticalreview
March 12, 2020
New research has found that there are 362 cell and gene therapies in clinical pipelines in the US, an increase from 2018.
ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule b3cnewswire
January 16, 2020
ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page